The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a less-invasive injection-free method of managing sight-stealing diseases such ...

Optegra Eye Health Care has become the first UK eye hospital group to introduce drop-free cataract surgery for NHS patients across all its hospitals and clinics. The approach, which involves ...

At the 131st Congress of the French Society of Ophthalmology in Paris, France, the role of second-generation intravitreal anti-VEGF injections compared to corticosteroid injections in treating ...

Macular telangiectasia (MacTel) type 2 is a disease that affects your macula, which is in your eye. It's an area in the center of your retina – the light-sensitive tissue at the back of your eye.

Background/aims Data on morphological characteristics and outcomes of extremely short eyes undergoing cataract surgery is sparse. Thus, an in-depth characterisation of eyes implanted with a high-power ...

Ophthalmologist, talks about wet and dry macular degeneration. Social Security, Medicare are "going to be gone," Donald Trump warns Tropical Storm Melissa could become a hurricane. See where it's ...

MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes, ...